Appointment positions company for strategic growth in next-generation protein sequencing GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointment of Jeff Keyes as its new Chief Financial Officer, effective May 15, 2023. Mr. Keyes brings more than 25 years of experience in senior financial positions providing transformational leadership for emerging […]

Männedorf, Switzerland – Tecan and DYNEX Technologies have announced a partnership to broaden the availability of quality ELISA products in the US. Customers will now have direct access to Tecan’s ELISA-related kits and comprehensive portfolio of reagents alongside DYNEX’s fully automated ELISA workstations. This exciting collaboration between two market leaders will vastly expand customer reach […]

Männedorf, Switzerland – Tecan and DYNEX Technologies have announced a partnership to broaden the availability of quality ELISA products in the US. Customers will now have direct access to Tecan’s ELISA-related kits and comprehensive portfolio of reagents alongside DYNEX’s fully automated ELISA workstations. This exciting collaboration between two market leaders will vastly expand customer reach across the […]

Blood-based measurement of neurofilament light chain (NfL) provides compelling evidence to support an accelerated drug approval by the FDA. The decision has positive implications for NfL blood testing as a key tool in neuro-drug development. BILLERICA, Mass – Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery and breakthrough diagnostics through ultrasensitive biomarker detection, today […]

Expanded facility to manufacture mRNA-based therapies and vaccines Researchers at the University of Adelaide will address the design and manufacturing of lipid nanoparticles (LNP) that help deliver mRNA into cells Cytiva and the University of Adelaide are collaborating with BioCina, an Australian-based multi-product biologics contract development and manufacturing organization (CDMO), to expand its facility in […]

Quantum-Si Strengthens Commercial, Operations, and Development Teams to Accelerate the Commercial Advancement of the Platinum™ Protein Sequencing Platform GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the appointments of Katherine Atkinson as Senior Vice President of Demand Generation and Corporate Brand, Alex Hutcheson as Senior Vice President of Sales and […]

DUBLIN, Ireland — Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, today announced it has entered into an agreement to sell its Fitzgerald Industries life sciences supply business, consisting of Benen Trading Ltd and Fitzgerald Industries International, Inc, to Biosynth for cash […]

SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration with Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura., “Astellas”), by which Astellas will license a suite of Twist’s VHH antibody libraries to be […]

Tromsø, Norway – ArcticZymes Technologies ASA (OSE:AZT) announces the launch of ArcticZymes Proteinase HQ to the B2B market. Following up on earlier press-releases (9th Dec 2022) ArcticZymes is pleased to launch the latest member in our Proteinase product portfolio: ArcticZymes Proteinase HQ. This product is the ‘bioprocessing grade’ version of our existing successful ArcticZymes Proteinase and […]

Leinco Technologies Highlights Launch of the new mAbMods™ chimeric anti-mouse PD1 and PD-L1 recombinant antibodies for use in in vivo functional studies ST. LOUIS — Leinco Technologies (“Leinco”) (St. Louis, MO), a biotechnology company and specialty manufacturer of antibodies, recombinant proteins, ELISA kits, and second step reagents, today announced the launch of the mAbMods™ chimeric […]